Mammary growth hormone and tumorigenesis – lessons from the dog

Veterinary Quarterly

Volumn 21, Issue 4, 1999, Pages 111-115

  Mol, J A ^a   Lantinga van Leeuwen, I S ^a   Selman, P J ^a   Oosterlaken Dijksterhuis, M A ^a   Schalken, J A ^a,b   Rijnberk, A ^a   van Garderen, E ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR;

ANIMAL; BIOSYNTHESIS; CELL DIVISION; CELL TRANSFORMATION; CYTOLOGY; DOG; EXPERIMENTAL NEOPLASM; FEMALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DOGS; FEMALE; GROWTH HORMONE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; RECEPTORS, SOMATOTROPIN;

EID: 0033210571     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1999.9695004     Document Type: Article

References (48)

1. Baxter RC, Binoux M, Clemmons DR, Conover C, Drop SLS, Holly JMP, Mohan S, Oh Y, and Rosenfeld RG. Recommendations for nomenclature of the insulin-like growth factor binding protein (IGFBP) superfamily. Growth hormone IGF Res 1998; 8: 273–4.
2. Birrell SN, Hall RE, and Tilley WD. Role of the androgen receptor in human breast cancer. J Mammary Gland Biol Neoplasia 1998; 3: 95–103.
3. Brisken C, Park S, Vass T, Lydon JP, O’Malley BW, and Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA, 1998; 28: 5076-81
4. Burrows H. In: Biological Actions of Sex Hormones, 2nd ed. Oxford: Cambridge University Press 1949.
5. Concannon P, Altszuler N, Hampshire J, Butler WR, and Hansel W. Growth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endocrinology 1980; 106: 1173–7.
6. Cullen KJ, Allison A, Martire I, Ellis M, and Singer C. Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res Treatm 1992; 22: 21–9.
7. Dastot F, Duquesnoy P, Sobrier M, Goossens M, and Amselem S. Evolutionary divergence of the truncated growth hormone receptor isoform in its ability to generate a soluble growth hormone binding protein. Mol Cell Endocrinol 1998; 137: 79–84.
8. Daughaday WH, and Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10: 68–91.
9. Edens A, and Talamantes F. Alternative processing of growth hormone receptor transcripts. Endocr Rev 1998; 19: 559–82.
10. Edgren RA. Issues in animal pharmacology. In: Pharmacology of the Contraceptive Steroids, JW Goldzieher ed., Raven Press Ltd. New York 1994: 81–97.
11. Editorial: ‘DMPA and breast cancer, the dog has had its day’. The Lancet 1991; 338: 856.
12. Eigenmann JE, Eigenmann RY, Rijnberk A, Gaag I van der, Zapf J, and Froesch ER. Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Copenh) 1983; 104:167–76.
13. Feldman M, Ruan W, Cunningham BC, Wells JA, and Kleinberg DL. Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland. Endocrinology 1993; 133:1602–8.
14. Frohman LA, Downs TR, and Chomczynski P. Regulation of growth hormone secretion. Frontiers in Neuroendocrinology 1992; 13: 344–405.
15. Graham JD, and Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997; 18, 502–19.
16. Green H, Morikawa M, and Nixon T. A dual effector theory of growthhormone action. Differentiation 1985; 29: 195–8.
17. Humphreys RC, Lydon J, O’Malley BW, and Rosen JM. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol 1997; 11, 801–11.
18. Jones JI, and Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3–35.
19. Keightly MC. Steroid receptor isoforms: exception or rule? Mol Cell Endocrinol 1998; 137: 1–5.
20. Kleinberg DL. Role of IGF-I in normal mammary development. Breast Cancer Res Treat 1998; 47: 201–8.
21. Kooistra HS, Voorhout G, Selman PJ, and Rijnberk A. Progestin-induced growth hormone (GH) production in the treatment of dogs with congenital GH deficiency. Domest Anim Endocrinol 1998; 15: 93–102.
22. Lantinga-van Leeuwen IS, Oudshoorn M, and Mol JA. Canine mammary growth hormone gene transcription initiates at the pituitary-specific start site in the absence of Pit-1. Mol Cell Endocrinol 1999; 150:121–8.
23. Lee AV, and Yee D. Insulin-like growth factors and breast cancer. Biomed Pharmacother 1995; 49: 415–21.
24. MacLeod JN, Worsley I, Ray J, Friesen HG, Liebhaber SA, and Cooke NE. Human growth hormOne-variant is a biologically active somatogen and lactogen. Endocrinology 1991; 128:1298–1302.
25. Misdorp W. Canine mammary tumours: protective effect of late ovariectomy and stimulating effect of progestins. Vet Quart 1988; 10: 26–33.
26. Mol JA, Garderen E van, Selman PJ, Wolfswinkel J, Rijnberk A, and Rutteman GR. Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 1995; 95: 2028–34.
27. Mol JA, Henzen-Logmans SC, Hageman Ph, Misdorp W, Blankenstein MR, and Rijnberk A. Expression of the gene encoding GH in the human mammary gland. J Clin Endocr Metab 1995; 80:3094–96.
28. Mol JA, Garderen E van, Rutteman GR, and Rijnberk A. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium; induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dpgs, cats and humans. J Steroid Biochem Mol Biol 1996; 57:67–71.
29. Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, and Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nature Medicine 1997; 10: 1141–4.
30. Oosterlaken-Dijksterhuis MA, Kwant MM, Slob A, Hellmén E, and Mol JA. IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335. Breast Cancer Res Treatm 1998; 1332: 1–13.
31. Pike MC, Spicer DV, Dahmoush L, and Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17–35.
32. Resnick CE, Fielder PJ, Rosenfeld RG, and Adashi EY. Characterization and hormonal regulation of a rat ovarian insulin-like growth factor binding protein-5 endopeptidase: an FSH-inducible granulosa cell-derived metalloprotease. Endocrinology 1998; 139: 1249–57.
33. Rutteman GR, Willekes-Koolschijn N, Bevers MM, Gugten AA van der, and Misdorp W. Prolactin binding in benign and malignant mammary tissue of female dogs. Anticancer Res 1986; 6: 829–35.
34. Rijnberk A, Eigenmann JE, Belshaw BE, and Hampshire J. Altszuler acromegaly associated with transient overproduction of growth hormone in a dog. N J Am Vet Med Assoc 1980; 177: 534–7.
35. Schedlich LJ, Young TF, Firth SM, and Baxter RC. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998; 17: 18347–52.
36. Selman PJ, Mol JA, Rutteman GR, and Rijnberk A. Progestins and growth hormone excess in the dog. Acta Endocrinol (Copenh)1991; 125, 42–7.
37. Selman PJ, Mol JA, Rutteman GR, and Rijnberk A. Progestin treatment in the dog. I Effects on growth hormone, insulin-like growth factor I and glucose homeostasis. Eur J Endocrino11994; 131: 413–21.
38. Selman PJ, Mol JA, Rutteman GR, and Rijnberk A. Progestin treatment in the dog II. Effects on the hypothalamic-pituitary-adrenocortical axis. Eur J Endocrinol 1994; 131: 422–30.
39. Selman PJ, Mol JA, Rutteman GR, Garderen E van, and Rijnberk A. Progestin induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 1994; 134: 287–92.
40. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, and Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 1998; 95: 696–701.
41. Surmacz E, Guvakova MA, Nolan MK, Nicosia RF, and Sciacca L. Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 1998; 47: 255–67.
42. Syvala H, Pekki A, Blauer M, Pasanen S, Makinen E, Ylikomi T, and Tuohimaa P. Hormone-dependent changes in A and B forms of progesterone receptor. J Steroid Biochem Mol Biol 1996; 58: 517–24.
43. Tonner E, Barber MC, Travers MT, Logan A, and Flint DJ. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 1997; 138:5101–57.
44. Tuggle CK, and Trenkle A. Control of growth hormone synthesis. Dom Animal Endocrinol 1996; 13: 1–33.
45. Van Garderen E, Wit M de, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H, and Misdorp W. Expression of growth hormone in canine mammary tissue and mammary tumors. Am J Pathol1997; 150: 1037–47.
46. Van Garderen E, Poel H van der, Swennenhuis JF, Wissink EHJ, Rutteman GR, Mol JA, and Schalken JA. Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology, accepted 1999.
47. Watson ADJ, Rutteman GR, Rijnberk A, and Mol JA. Effect of somatostatin analogue sms 201-995 and antiprogestin agent RU 486 in canine acromegaly. Front Horm Res 1987; 1: 193–8.
48. Wei LL, Hawkins P, Baker C, Norris B, Sheridan PL, and Quinn PG. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity. Mol Endocrinol 1996; 10: 1379–87.